
RxSight (RXST) Stock Forecast & Price Target
RxSight (RXST) Analyst Ratings
Bulls say
RxSight Inc. has demonstrated solid growth and operational stability, with a reported revenue increase that surpassed consensus expectations, indicating effective business strategies and strong demand for its light adjustable lenses. The company’s management has taken a more strategic approach to product placements, focusing on initiatives designed to enhance customer engagement and drive higher volumes, which contributes to a robust outlook for future revenue growth. Additionally, the raised gross margin guidance to 76-77% reflects improved operational efficiency and potential for significant profitability, while ongoing factors such as faster installed base growth and better product utilization serve as positive indicators for RxSight's financial performance moving forward.
Bears say
RxSight Inc. has experienced a notable decline in key performance metrics, particularly in monthly utilization rates of light adjustable lenses (LALs), which dropped to 8.0 per lens delivery device (LDD) in 3Q25 from 8.7 in 2Q25 and 10.1 in 3Q24. The company's fiscal guidance for FY2026 revenue is projected to be between $120M and $135M, representing a decrease of 11% to flat year-over-year, which falls short of previous market expectations. Additionally, while operating expenses decreased slightly to $36.6M year-over-year, the impending impact of higher-cost inventory on gross margins is anticipated to contribute to further sequential revenue contraction through the end of 2026.
This aggregate rating is based on analysts' research of RxSight and is not a guaranteed prediction by Public.com or investment advice.
RxSight (RXST) Analyst Forecast & Price Prediction
Start investing in RxSight (RXST)
Order type
Buy in
Order amount
Est. shares
0 shares